AKR1B1 and central nervous system cancer: Given that AKR1B1-expressing glioma cells inhibited cell growth (Figure 3A,B) and induced activation of p38 MAPK signaling (Figure 4A,B), the p38 MAPK pathway has been shown to play a role in inducing apoptosis or programmed cell death in cancer cells [35,36].